FindTrial
Sign In

Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes Respiration

Effect of Adaptive Servoventilation on Cardiac Function, Exercise Tolerance and Quality of Life in Patients With Chronic Heart Failure and Cheyne-Stokes Respiration

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01212705
Enrollment
Unknown
Registered
2010-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2010-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Sleep Apnea, Cheyne-Stokes Respiration, Chronic Heart Failure

Brief summary

Sleep disordered breathing is common in patients with chronic heart failure. Adaptive servoventilation is a novel method of treatment central sleep apnoea, especially associated with Cheyne-Stokes-respiration. The aim of the study is to investigate effect of adaptive servoventilation on cardiac function, exercise tolerance and quality of life in patients with chronic heart failure.

Interventions

DEVICEAdaptive servoventilation

Background expiratory positive airway pressure with some inspiratory pressure support when needed

Sponsors

Military Institute od Medicine National Research Institute
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* chronic heart failure with ejection fraction ≤45% * optimal medical treatment for at least 1 month * clinical diagnosis of Cheyne-Stokes respiration

Exclusion criteria

* unstable heart failure * stroke * transient ischemic attack in last 6 months * pacemaker, cardioverter-defibrillator or resynchronization device implanted less than 6 months before study entrance * severe chronic obstructive pulmonary disease

Countries

Poland

Contacts

Primary ContactAnna Kazimierczak
annakazimierczak@poczta.onet.pl48 22 6818017
Backup ContactKrystian Krzyzanowski
krystian.krzyzanowski@gmail.com48 512 356 207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026